A review posted in JAMA Network Open up emphasizes the discrepancy amongst what it prices to generate copyright plus the retail selling prices people encounter. Regardless of the very low generation costs, Novo Nordisk has not publicly disclosed distinct figures for copyright or its other product, Wegovy.Novo Nordisk is involved with govt funded co